세계의 뇌하수체 왜소증 치료 시장 보고서(2025년)

Pituitary Dwarf Treatment Global Market Report 2025

US $ 4,490 ￦ 6,496,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,390,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,284,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

뇌하수체 왜소증 치료 시장 규모는 향후 몇 년 동안 연평균 13.9%의 성장률을 기록하며 2029년에는 107억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 노인 인구 증가, 의료비 지출 증가, 성장 호르몬 치료, 뇌하수체 소인증에 대한 처방 치료 수요 증가에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 의학 연구의 발전, 의약품 승인, 약물 전달 시스템의 발전, 혁신적인 성장 호르몬 제제, 유전자 검사 등이 있습니다.

성장호르몬 분비 결핍증(GHD)의 유병률 증가는 뇌하수체 소인증 치료 시장의 성장을 가속할 것으로 예상되며, GHD는 뇌하수체가 충분한 성장호르몬(GH)을 생산하거나 분비할 수 없는 질환입니다. 뇌하수체 왜소증 치료에는 성장 촉진, 뼈 건강 개선, 신진대사 조절, 성장 호르몬 결핍 및 왜소증 환자의 삶의 질 향상을 목표로 하는 호르몬 요법이 포함됩니다. 예를 들어, 2023년 11월 사우디아라비아의 정부 기관인 건강 보험 위원회는 2022년 사우디아라비아의 저신장 유병률이 33.68%이며, 성장 호르몬 결핍이 내분비학적인 원인 중 1위로 9.7%를 차지한다고 보고했습니다. 그 결과, 성장호르몬 결핍증 유병률 증가가 뇌하수체 소인증 치료 시장의 성장을 주도하고 있습니다.

호르몬 장애의 유병률 증가는 뇌하수체 소인증 치료 시장의 성장을 가속할 것으로 예상됩니다. 호르몬 장애는 체내 호르몬을 조절하는 내분비계가 정상적으로 작동하지 않는 상태입니다. 이 시스템의 주요 구성 요소인 뇌하수체는 성장과 발달에 중요한 역할을 하는 성장 호르몬(GH)을 비롯한 여러 호르몬의 생산과 분비를 조절합니다. 예를 들어, 2024년 6월 영국 정부 기관인 국민보건서비스(NHS)는 호르몬 장애로 진단받은 40세 미만 인구가 2022년 173,166명에서 2023년 216,440명으로 크게 증가했다고 보고했습니다. 이러한 증가는 호르몬 불균형과 관련된 당뇨병과 같은 질병에서 특히 두드러집니다. 호르몬 장애가 보편화됨에 따라 뇌하수체 소인증 및 성장 호르몬 결핍증과 같은 증상을 치료하는 치료에 대한 수요가 증가하여 뇌하수체 소인증 치료 시장의 성장을 견인할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 뇌하수체 왜소증 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업 분석
• 세계의 뇌하수체 왜소증 치료 시장 : 성장률 분석
• 세계의 뇌하수체 왜소증 치료 시장 실적 : 규모와 성장, 2019-2024
• 세계의 뇌하수체 왜소증 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 뇌하수체 왜소증 치료 전체 시장(TAM)

제6장 시장 세분화

• 세계의 뇌하수체 왜소증 치료 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 뇌하수체 왜소증 I형
• 뇌하수체 왜소증 II형
• 뇌하수체 왜소증 III형
• 뇌하수체 왜소증 IV형
• 기타 유형
• 세계의 뇌하수체 왜소증 치료 시장 : 치료별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 수술
• 추가 요법
• 약물
• 기타 치료법
• 세계의 뇌하수체 왜소증 치료 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 비경구
• 기타 투여 경로
• 세계의 뇌하수체 왜소증 치료 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 홈케어
• 전문 클리닉
• 세계의 뇌하수체 왜소증 치료 시장 : 뇌하수체 왜소증 I형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 성장호르몬 결핍증
• 하수체 기능 저하증
• 세계의 뇌하수체 왜소증 치료 시장 : 뇌하수체 왜소증 II형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 성장호르몬 단독 결손증
• 하수체 호르몬 복합 결핍증
• 세계의 뇌하수체 왜소증 치료 시장 : 뇌하수체 왜소증 III형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 선천 이상
• 유전성 질환
• 세계의 뇌하수체 왜소증 치료 시장 : 뇌하수체 왜소증 IV형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 후천적인 원인
• 기타 호르몬 불균형
• 세계의 뇌하수체 왜소증 치료 시장 : 기타 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 특발성 소인증
• 증후군성 소인증

제7장 지역별/국가별 분석

• 세계의 뇌하수체 왜소증 치료 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 뇌하수체 왜소증 치료 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 뇌하수체 왜소증 치료 시장 : 경쟁 구도
• 뇌하수체 왜소증 치료 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck and Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Novo Nordisk A/S
• H. Lundbeck A/S
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd
• Ipsen Pharma S.A.
• Genentech Inc.
• Apotex Inc.
• Cipla Limited
• Ferring Pharmaceuticals
• Anhui Anke Biotechnology(Group) Co Ltd.
• Amneal Pharmaceuticals LLC.
• BioMarin Pharmaceutical Inc.
• Biopartners GmbH
• Elekta AB
• Xiamen Amoytop Biotech Co Ltd

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 뇌하수체 왜소증 치료 시장(2029년) : 새로운 기회를 제공하는 국가
• 뇌하수체 왜소증 치료 시장(2029년) : 새로운 기회를 제공하는 부문
• 뇌하수체 왜소증 치료 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Pituitary dwarfism is a medical condition where the pituitary gland fails to produce an adequate amount of growth hormone (GH), resulting in impaired growth and development, ultimately leading to short stature or dwarfism. Treatment for pituitary dwarfism aims to stimulate the growth of bones, muscles, and other tissues, resulting in a noticeable increase in height and overall physical development.

The primary categories of pituitary dwarfism treatment include pituitary dwarfism type I, pituitary dwarfism type II, pituitary dwarfism type III, pituitary dwarfism type IV, and others. Pituitary dwarfism type I, also known as isolated growth hormone deficiency type I, is a medical condition characterized by insufficient production of growth hormone (GH) from the pituitary gland. Various treatment options are available, including surgery, additional therapies, drugs, and others. These treatments are administered through different routes, including parenteral and others, and are utilized by various end-users, such as hospitals, homecare, specialty clinics, and others.

The pituitary dwarf treatment market research report is one of a series of new reports from The Business Research Company that provides pituitary dwarf treatment market statistics, including pituitary dwarf treatment industry global market size, regional shares, competitors with a pituitary dwarf treatment market share, detailed pituitary dwarf treatment market segments, market trends and opportunities and any further data you may need to thrive in the pituitary dwarf treatment industry. This pituitary dwarf treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pituitary dwarf treatment market size has grown rapidly in recent years. It will grow from $5.52 billion in 2024 to $6.38 billion in 2025 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to increasing demand for pituitary dwarf treatment drugs, growing prevalence of pituitary dwarfism, awareness of pituitary dwarfism.

The pituitary dwarf treatment market size is expected to see rapid growth in the next few years. It will grow to $10.74 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to rising geriatric population, rising healthcare spending, growth hormone treatment, growing demand for prescription treatments for pituitary dwarfism. Major trends in the forecast period include advancements in medical research, drug approvals, advancements in drug delivery systems, innovative growth hormone formulations, genetic testing.

The increasing prevalence of growth hormone deficiency (GHD) is expected to drive the growth of the pituitary dwarf treatment market. GHD is a medical condition where the pituitary gland fails to produce or secrete sufficient growth hormone (GH). Treatments for pituitary dwarfism include hormonal therapies aimed at promoting growth, improving bone health, regulating metabolism, and enhancing the quality of life for individuals suffering from growth hormone deficiency and dwarfism. For example, in November 2023, the Council of Health Insurance, a Saudi Arabia-based government office, reported that in 2022, the overall prevalence of short stature in Saudi Arabia was 33.68%, with growth hormone deficiency being the leading endocrinological cause, accounting for 9.7% of cases. As a result, the rising prevalence of growth hormone deficiency is driving the growth of the pituitary dwarf treatment market.

The rise in the prevalence of hormonal disorders is expected to drive the growth of the pituitary dwarf treatment market. Hormonal disorders are conditions where the endocrine system, which regulates hormones in the body, does not function properly. The pituitary gland, a key component of this system, controls the production and release of several hormones, including growth hormone (GH), which plays a critical role in growth and development. For instance, in June 2024, the National Health Service (NHS), a UK-based government department, reported a significant increase in the number of people under 40 diagnosed with hormonal disorders, rising from 173,166 in 2022 to 216,440 in 2023. This rise is particularly notable in conditions like diabetes, which is associated with hormonal imbalances. As hormonal disorders become more prevalent, the demand for treatments addressing conditions like pituitary dwarfism and growth hormone deficiency is expected to grow, driving the expansion of the pituitary dwarf treatment market.

The leading companies within the pituitary dwarf treatment market are actively directing their efforts toward the development of innovative products to maintain and advance their standing within the market. For example, in April 2023, Novo Nordisk A/S, a pharmaceutical company headquartered in Denmark, launched Sogroya (somapacitan-beco) injections in 5 mg, 10 mg, and 15 mg variants, following approval from the U.S. Food and Drug Administration (FDA). This novel offering is designed to address growth deficiencies in children aged 2.5 years and older, stemming from insufficient endogenous growth hormone secretion. With this newly added indication, Sogroya now stands as the sole once-weekly growth hormone (GH) medication available for both children and adults.

The rising healthcare spending is expected to drive the growth of the pituitary dwarf treatment market. Healthcare spending refers to the financial resources allocated to health services, public health initiatives, medical research, and healthcare infrastructure. Factors contributing to increased healthcare spending include the growing prevalence of chronic diseases, an aging population, and advancements in medical technologies, which lead to a higher demand for specialized treatments and therapies. Pituitary dwarf treatment plays a role in this by increasing the need for hormone therapies, medical care, and long-term management of conditions such as growth hormone deficiency. For example, in December 2023, the Centers for Medicare and Medicaid Services (CMS), a US federal agency, reported that US healthcare spending grew by 4.1% in 2023, reaching $4.5 trillion, surpassing the 3.2% increase seen in 2021. Spending on hospital care services alone grew by 2.2%, totaling $1.4 trillion. As healthcare expenditure continues to rise, the pituitary dwarf treatment market is expected to benefit from the increased demand for specialized treatments and care.

Major companies operating in the pituitary dwarf treatment market are Pfizer Inc., Merck and Co Inc., Novartis AG, Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, H. Lundbeck A/S, Mylan N.V., Teva Pharmaceutical Industries Ltd., Ipsen Pharma S.A., Genentech Inc., Apotex Inc., Cipla Limited, Ferring Pharmaceuticals, Anhui Anke Biotechnology (Group) Co Ltd., Amneal Pharmaceuticals LLC., BioMarin Pharmaceutical Inc., Biopartners GmbH, Elekta AB, Xiamen Amoytop Biotech Co Ltd., Lifetech Labs, Alnylam Pharmaceuticals Inc., GeneScience Pharmaceuticals Co Ltd., Armata Pharmaceuticals Inc., Alkermes Plc.

North America was the largest region in the pituitary dwarf treatment market in 2024. The regions covered in pituitary dwarf treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pituitary dwarf treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pituitary dwarf treatment market consists of revenues earned by entities by providing hormone replacement therapy (HRT), combined hormone therapy, synthetic human growth hormone injections and surgical interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The pituitary dwarf treatment market also includes sales of somatropin, bromocriptine and octreotide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pituitary Dwarf Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pituitary dwarf treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pituitary dwarf treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pituitary dwarf treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Pituitary Dwarfism Type I; Pituitary Dwarfism Type II; Pituitary Dwarfism Type III; Pituitary Dwarfism Type IV; Other Types
• 2) By Treatment: Surgery; Additional Therapy; Drugs; Other Treatments
• 3) By Route Of Administration: Parenteral; Other Routes Of Administrations
• 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Pituitary Dwarfism Type I: Growth Hormone Deficiency; Hypopituitarism
• 2) By Pituitary Dwarfism Type II: Isolated Growth Hormone Deficiency; Combined Pituitary Hormone Deficiency
• 3) By Pituitary Dwarfism Type III: Congenital Anomalies; Genetic Disorders
• 4) By Pituitary Dwarfism Type IV: Acquired Causes; Other Hormonal Imbalances
• 5) By Other Types: Idiopathic Dwarfism; Syndromic Dwarfism
• Companies Mentioned: Pfizer Inc.; Merck and Co Inc.; Novartis AG; Sanofi S.A.; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pituitary Dwarf Treatment Market Characteristics

3. Pituitary Dwarf Treatment Market Trends And Strategies

4. Pituitary Dwarf Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pituitary Dwarf Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pituitary Dwarf Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pituitary Dwarf Treatment Market Growth Rate Analysis
• 5.4. Global Pituitary Dwarf Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pituitary Dwarf Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pituitary Dwarf Treatment Total Addressable Market (TAM)

6. Pituitary Dwarf Treatment Market Segmentation

• 6.1. Global Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pituitary Dwarfism Type I
• Pituitary Dwarfism Type II
• Pituitary Dwarfism Type III
• Pituitary Dwarfism Type IV
• Other Types
• 6.2. Global Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Additional Therapy
• Drugs
• Other Treatments
• 6.3. Global Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral
• Other Routes Of Administrations
• 6.4. Global Pituitary Dwarf Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• 6.5. Global Pituitary Dwarf Treatment Market, Sub-Segmentation Of Pituitary Dwarfism Type I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Growth Hormone Deficiency
• Hypopituitarism
• 6.6. Global Pituitary Dwarf Treatment Market, Sub-Segmentation Of Pituitary Dwarfism Type II, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Isolated Growth Hormone Deficiency
• Combined Pituitary Hormone Deficiency
• 6.7. Global Pituitary Dwarf Treatment Market, Sub-Segmentation Of Pituitary Dwarfism Type III, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Congenital Anomalies
• Genetic Disorders
• 6.8. Global Pituitary Dwarf Treatment Market, Sub-Segmentation Of Pituitary Dwarfism Type IV, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acquired Causes
• Other Hormonal Imbalances
• 6.9. Global Pituitary Dwarf Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Idiopathic Dwarfism
• Syndromic Dwarfism

7. Pituitary Dwarf Treatment Market Regional And Country Analysis

• 7.1. Global Pituitary Dwarf Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pituitary Dwarf Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pituitary Dwarf Treatment Market

• 8.1. Asia-Pacific Pituitary Dwarf Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pituitary Dwarf Treatment Market

• 9.1. China Pituitary Dwarf Treatment Market Overview
• 9.2. China Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pituitary Dwarf Treatment Market

• 10.1. India Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pituitary Dwarf Treatment Market

• 11.1. Japan Pituitary Dwarf Treatment Market Overview
• 11.2. Japan Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pituitary Dwarf Treatment Market

• 12.1. Australia Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pituitary Dwarf Treatment Market

• 13.1. Indonesia Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pituitary Dwarf Treatment Market

• 14.1. South Korea Pituitary Dwarf Treatment Market Overview
• 14.2. South Korea Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pituitary Dwarf Treatment Market

• 15.1. Western Europe Pituitary Dwarf Treatment Market Overview
• 15.2. Western Europe Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pituitary Dwarf Treatment Market

• 16.1. UK Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pituitary Dwarf Treatment Market

• 17.1. Germany Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pituitary Dwarf Treatment Market

• 18.1. France Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pituitary Dwarf Treatment Market

• 19.1. Italy Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pituitary Dwarf Treatment Market

• 20.1. Spain Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pituitary Dwarf Treatment Market

• 21.1. Eastern Europe Pituitary Dwarf Treatment Market Overview
• 21.2. Eastern Europe Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pituitary Dwarf Treatment Market

• 22.1. Russia Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pituitary Dwarf Treatment Market

• 23.1. North America Pituitary Dwarf Treatment Market Overview
• 23.2. North America Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pituitary Dwarf Treatment Market

• 24.1. USA Pituitary Dwarf Treatment Market Overview
• 24.2. USA Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pituitary Dwarf Treatment Market

• 25.1. Canada Pituitary Dwarf Treatment Market Overview
• 25.2. Canada Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pituitary Dwarf Treatment Market

• 26.1. South America Pituitary Dwarf Treatment Market Overview
• 26.2. South America Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pituitary Dwarf Treatment Market

• 27.1. Brazil Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pituitary Dwarf Treatment Market

• 28.1. Middle East Pituitary Dwarf Treatment Market Overview
• 28.2. Middle East Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pituitary Dwarf Treatment Market

• 29.1. Africa Pituitary Dwarf Treatment Market Overview
• 29.2. Africa Pituitary Dwarf Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pituitary Dwarf Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pituitary Dwarf Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pituitary Dwarf Treatment Market Competitive Landscape And Company Profiles

• 30.1. Pituitary Dwarf Treatment Market Competitive Landscape
• 30.2. Pituitary Dwarf Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck and Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Pituitary Dwarf Treatment Market Other Major And Innovative Companies

• 31.1. Novo Nordisk A/S
• 31.2. H. Lundbeck A/S
• 31.3. Mylan N.V.
• 31.4. Teva Pharmaceutical Industries Ltd
• 31.5. Ipsen Pharma S.A.
• 31.6. Genentech Inc.
• 31.7. Apotex Inc.
• 31.8. Cipla Limited
• 31.9. Ferring Pharmaceuticals
• 31.10. Anhui Anke Biotechnology (Group) Co Ltd.
• 31.11. Amneal Pharmaceuticals LLC.
• 31.12. BioMarin Pharmaceutical Inc.
• 31.13. Biopartners GmbH
• 31.14. Elekta AB
• 31.15. Xiamen Amoytop Biotech Co Ltd

32. Global Pituitary Dwarf Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pituitary Dwarf Treatment Market

34. Recent Developments In The Pituitary Dwarf Treatment Market

35. Pituitary Dwarf Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Pituitary Dwarf Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pituitary Dwarf Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pituitary Dwarf Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료